Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Limiting dilution assays are widely used in infectious disease research. These assays are crucial for current human immunodeficiency virus (HIV)-1 cure research in particular. In this study, we offer new tools to help investigators design and analyze dilution assays based on their specific research needs. Limiting dilution assays are commonly used to measure the extent of infection, and in the context of HIV they represent an essential tool for studying latency and potential curative strategies. Yet standard assay designs may not discern whether an intervention reduces an already miniscule latent infection. This review addresses challenges arising in this setting and in the general use of dilution assays. We illustrate the major statistical method for estimating frequency of infectious units from assay results, and we offer an online tool for computing this estimate. We recommend a procedure for customizing assay design to achieve desired sensitivity and precision goals, subject to experimental constraints. We consider experiments in which no viral outgrowth is observed and explain how using alternatives to viral outgrowth may make measurement of HIV latency more efficient. Finally, we discuss how biological complications, such as probabilistic growth of small infections, alter interpretations of experimental results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098 · cited 15×
“Towards this goal, we present principles for the design and interpretation of dilution assays, discuss these principles in the context of HIV-1 latency, and offer a simple computational tool for estimating the frequency of latently infected cells in a sample (“infectious units per million” or “IUPM”) from assay result…”
BackgroundMethodInfluentialSelf-citationSiliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703 · cited 14×
“Towards this goal, we present principles for the design and interpretation of dilution assays, discuss these principles in the context of HIV-1 latency, and offer a simple computational tool for estimating the frequency of latently infected cells in a sample (“infectious units per million” or “IUPM”) from assay result…”
BackgroundInfluentialSelf-citationReplication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405 · cited 2×
“sion may stall initiation of HIV transcription [3, 27].”
BackgroundSelf-citationHuman memory T cells: generation, compartmentalization and homeostasis
Farber, D. L., Yudanin, N. A., & Restifo, N. P. (2014) · Nature Reviews Immunology · doi:10.1038/nri3567 · Cited by 897 · cited 1×
“If desired, this fraction can be scaled by an appropriate number (approximately 10(11) to 10(12) total resting CD4 T cells in a human body [16]) to estimate total latent reservoir size.”
Background
Cited by
Defective proviruses rapidly accumulate during acute HIV-1 infection
Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737
Self-citationA quantitative approach for measuring the reservoir of latent HIV-1 proviruses
Bruner, K. M., Wang, Z., Simonetti, F. R., Bender, A. M., Kwon, K. J., Sengupta, S., Fray, E. J., Beg, S. A., Antar, A. A. R., Jenike, K. M., et al. (2019) · Nature · doi:10.1038/s41586-019-0898-8 · Cited by 718
Self-citationHosmane, N. N., Kwon, K. J., Bruner, K. M., Capoferri, A. A., Beg, S., Rosenbloom, D. I. S., Keele, B. F., Ho, Y.-C., Siliciano, J. D., & Siliciano, R. F. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170193 · Cited by 381
Self-citationCD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Descours, B., Petitjean, G., López-Zaragoza, J.-L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. (2017) · Nature · doi:10.1038/nature21710 · Cited by 242
Pardons, M., Baxter, A. E., Massanella, M., Pagliuzza, A., Fromentin, R., Dufour, C., Leyre, L., Routy, J.-P., Kaufmann, D. E., & Chomont, N. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007619 · Cited by 227
Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo
Simonetti, F. R., Zhang, H., Soroosh, G. P., Duan, J., Rhodehouse, K., Hill, A. L., Beg, S. A., McCormick, K., Raymond, H. E., Nobles, C. L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145254 · Cited by 164
Self-citationSustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
Gaebler, C., Kor, S., Allers, K., Perotti, M., Mwangi, D., Meixenberger, K., Hanke, K., Trenkner, T., Kraus, T., Sha, Y., et al. (2026) · Nature · doi:10.1038/s41586-025-09893-0 · Cited by 16
“The infectious HIV units were quantified using the IUPMStats (v. 1.0) calculator with an estimated LLOD of 0.05 (first time point, 62 months after treatment interruption) or 0.006 (second time point, 78 months after treatment interruption) infectious units per million CD4 T cells, respectively 65 .”
InfluentialOtte, F., Zhang, Y., Spagnuolo, J., Thielen, A., Däumer, M., Wiethe, C., Stoeckle, M., Kusejko, K., Klein, F., Metzner, K. J., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100485 · Cited by 4
Metadata
- Authors
- Rosenbloom, D. I. S., Elliott, O., Hill, A. L., Henrich, T. J., Siliciano, J. M., & Siliciano, R. F.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015
- Volume
- 2
- Issue
- 4
- Pages
- ofv123-ofv123
- ISSN
- 2328-8957 (ISSN-L)
- OpenAlex
- W1771860521
- Cited by
- 128
- References
- 4
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.